top of page
Spravato® Esketamine
Discover Relief with Spravato® Esketamine Therapy
An FDA-Approved Solution for Treatment-Resistant Depression
Spravato®: A New Path to Mental Health Relief
Spravato® (esketamine) is an innovative, FDA-approved treatment specifically designed for individuals struggling with treatment-resistant depression (TRD). Unlike traditional antidepressants, Spravato® works rapidly to target symptoms, providing hope for those who have not found success with conventional therapies.
Administered in a controlled clinical setting under the supervision of a trained healthcare provider, Spravato® is a nasal spray that, combined with oral antidepressants, helps restore balance and improve mental health.
Key Benefits of Spravato® Therapy:
Fast-acting relief for symptoms of treatment-resistant depression.
Administered in a safe, monitored environment.
Provides hope for individuals who haven’t responded to traditional treatments.
Take the next step in your mental health journey with Georgia Behavioral Health. Our team is here to guide you through the Spravato® treatment process and help you regain control of your life.
Start Your Healing Journey
Contact us today to learn more about Spravato® therapy and find out if it’s right for you.
FAQs:
1. What is Spravato®?
Spravato® is an FDA-approved nasal spray containing esketamine, a rapid-acting treatment for individuals with treatment-resistant depression. It is used alongside oral antidepressants to improve mental health.
2. How does Spravato® work?
Spravato® targets specific receptors in the brain associated with mood regulation. By restoring chemical imbalances, it helps alleviate symptoms of depression more quickly than traditional antidepressants.
3. What is the difference between esketamine and ketamine?
Esketamine is a derivative of ketamine, specifically developed and FDA-approved for depression treatment. Ketamine, while also effective, is often used off-label for mental health conditions.
4. What can I expect from Spravato® depression treatment?
Spravato® is administered under medical supervision. During the session, patients use the nasal spray in a comfortable, monitored setting and are observed for two hours. Most patients experience noticeable symptom relief after a few sessions.
5. Are there side effects of Spravato®?
Common side effects include dizziness, nausea, sedation, and temporary dissociation. These are typically mild and resolve shortly after the session.
6. What does Spravato® treat, and am I a candidate?
Spravato® is FDA-approved for treatment-resistant depression and is an option for individuals who have not responded to multiple traditional antidepressants. A thorough evaluation by a healthcare provider can confirm your eligibility.
bottom of page